Literature DB >> 12566749

Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis.

Alfonsa Pizzo1, Francesca M Salmeri, Francesca V Ardita, Vincenza Sofo, Maria Tripepi, Silvano Marsico.   

Abstract

Endometriosis is a disorder characterised by presence and growth of endometrial tissue outside the uterus, primarily into the peritoneum. The peritoneal fluid (PF) of women with endometriosis undergoes a number of biological changes, including local inflammatory-reparative phenomena and peripheral blood mononuclear cells (PBMC) involvement. These activated cells as well as the endometriotic cells secrete various cytokines with pleiotropic biological activities. Dynamic interplay among cytokines may contribute to realise a favourable microenvironment for the implantation of endometrial cells and the progression of the disease. In the present study, we evaluated the levels of cytokines, such as the tumour necrosis factor-alpha (TNF-alpha), transforming growth factor-beta (TGF-beta), interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) in PF and in serum (S) of women with endometriosis to compare their behaviour in both biological fluids. The patients (n = 26) were women of reproductive age attending our observation centre for infertility, diagnosed endometriosis at laparoscopy. Control group (n = 5) consisted of women affected by non-immunologic infertility, diagnosed by explorative laparoscopy. S samples were obtained from peripheral blood before anaesthesia and laparoscopy. PF samples were collected at the time of laparoscopy. Both biological fluids were examined for cytokine by ELISA assays. Our results showed that S and PF levels of TNF-alpha, not dosable in controls, were very high at the early stage and decreased significantly with the severity of the disease (p < 0.001). TGF-beta levels were significantly (p < 0.001) higher than in controls and increased with the severity of the disease (p < 0.001), particularly in the PF. S and PF IL-8 as well as MCP-1 concentrations at all stages were higher than in controls (p < 0.001), yet showed an opposite behaviour in both biological fluids. In fact, S levels of IL-8 and MCP-1 were significantly (p < 0.001) higher at early stages and decreased with the severity of the disease, whereas we observed a significant (p < 0.001) enhancement of these chemokine levels in PF from stage I to stage II and stage III. These observations showed that TNF-alpha and TGF-beta levels were overlapping in S and PF of women with endometriosis. On the contrary, MCP-1 and IL-8 S concentrations decreased with the severity of the disease, whereas PF levels showed markedly increased at severe stages. Taken together the observed changes may be due both to the increased peritoneal macrophage activity and to the larger recruitment of PBMC and autocrine release by endometriotic cells. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12566749     DOI: 10.1159/000067717

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  52 in total

1.  The endometrial response to chorionic gonadotropin is blunted in a baboon model of endometriosis.

Authors:  J R A Sherwin; J M Hastings; K S Jackson; P A Mavrogianis; A M Sharkey; A T Fazleabas
Journal:  Endocrinology       Date:  2010-07-28       Impact factor: 4.736

Review 2.  Peripheral biomarkers of endometriosis: a systematic review.

Authors:  K E May; S A Conduit-Hulbert; J Villar; S Kirtley; S H Kennedy; C M Becker
Journal:  Hum Reprod Update       Date:  2010-05-12       Impact factor: 15.610

3.  Screening the role of pronociceptive molecules in a rodent model of endometriosis pain.

Authors:  Pedro Alvarez; Jon D Levine
Journal:  J Pain       Date:  2014-04-20       Impact factor: 5.820

4.  Behavior of tumor necrosis factor-α and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages.

Authors:  Francesca M Salmeri; Antonio S Laganà; Vincenza Sofo; Onofrio Triolo; Emanuele Sturlese; Giovanni Retto; Alfonsa Pizzo; Angela D'Ascola; Salvatore Campo
Journal:  Reprod Sci       Date:  2014-05-20       Impact factor: 3.060

5.  Proteomic analysis of serum yields six candidate proteins that are differentially regulated in a subset of women with endometriosis.

Authors:  Beata Seeber; Mary D Sammel; Xuejun Fan; George L Gerton; Alka Shaunik; Jesse Chittams; Kurt T Barnhart
Journal:  Fertil Steril       Date:  2009-02-20       Impact factor: 7.329

Review 6.  Endometriosis: a high-risk population for major chronic diseases?

Authors:  Marina Kvaskoff; Fan Mu; Kathryn L Terry; Holly R Harris; Elizabeth M Poole; Leslie Farland; Stacey A Missmer
Journal:  Hum Reprod Update       Date:  2015-03-11       Impact factor: 15.610

7.  Elevated peritoneal fluid TNF-α incites ovarian early growth response factor 1 expression and downstream protease mediators: a correlation with ovulatory dysfunction in endometriosis.

Authors:  Julie A Birt; Henda Nabli; Julie A Stilley; Emma A Windham; Shellaine R Frazier; Kathy L Sharpe-Timms
Journal:  Reprod Sci       Date:  2013-02-20       Impact factor: 3.060

8.  The vitamin E-binding protein afamin is altered significantly in the peritoneal fluid of women with endometriosis.

Authors:  Beata E Seeber; Theresa Czech; Hannes Buchner; Kurt T Barnhart; Christoph Seger; Guenter Daxenbichler; Ludwig Wildt; Hans Dieplinger
Journal:  Fertil Steril       Date:  2010-06-17       Impact factor: 7.329

9.  PAI-1 secretion of endometrial and endometriotic cells is Smad2/3- and ERK1/2-dependent and influences cell adhesion.

Authors:  Cong Sui; Ezekiel Mecha; Charles Oa Omwandho; Anna Starzinski-Powitz; Angelika Stammler; Hans-Rudolf Tinneberg; Lutz Konrad
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 10.  Blood biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Rabia Shaikh; Cindy Farquhar; Vanessa Jordan; Carola S Scheffers; Ben Willem J Mol; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.